Correction: Tubeimuside I improves the efficacy of a therapeutic Fusobacterium nucleatum dendritic cell-based vaccine against colorectal cancer

Correction: Tubeimuside I improves the efficacy of a therapeutic Fusobacterium nucleatum dendritic cell-based vaccine against colorectal cancer

Saved in:

Bibliographic Details
Main Authors:	Yanan Tong, Guoxiu Lu, Zhiguo Wang, Shanhu Hao, Guoxu Zhang, Hongwu Sun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Immunology
Subjects:	colorectal cancer F. nucleatum tubeimuside I dendritic cells vaccine
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1639717/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tubeimuside I improves the efficacy of a therapeutic Fusobacterium nucleatum dendritic cell-based vaccine against colorectal cancer
by: Yanan Tong, et al.
Published: (2023-05-01)

The rise and evolving role of Fusobacterium nucleatum subspecies
by: Marietta Wolf, et al.
Published: (2025-01-01)

Lipid accumulation inhibition strategies alleviate Fusobacterium nucleatum-infected colorectal cancer
by: Zhongkun Zhou, et al.
Published: (2025-08-01)

Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study
by: Mmadili N. Ilozumba, et al.
Published: (2024-11-01)

Association of Fusobacterium nucleatum infection with colorectal cancer in Kazakhstani patients
by: Gulmira Kulmambetova, et al.
Published: (2024-12-01)

Association of Fusobacterium nucleatum with colorectal cancer molecular subtypes and its outcome: a systematic review
by: Luana Greco, et al.
Published: (2025-01-01)

Reexamining the role of Fusobacterium nucleatum subspecies in clinical and experimental studies
by: Madeline Krieger, et al.
Published: (2024-12-01)

Microbial manipulators: Fusobacterium nucleatum modulates the tumor immune microenvironment in colorectal cancer
by: Qian Li, et al.
Published: (2025-12-01)

Fusobacterium nucleatum downregulated MLH1 expression in colorectal cancer by activating autophagy-lysosome pathway
by: Tingting Ding, et al.
Published: (2025-05-01)

A Longitudinal Dynamic Change in LMR Can Be a Biomarker for Recurrence in Fusobacterium Nucleatum-Positive Colorectal Cancer Patients
by: Chen S, et al.
Published: (2024-12-01)

The presence and relative abundance of salivary Fusobacterium nucleatum are not associated with colorectal cancer: a systematic review and meta-analysis
by: Ellay Gutmacher, et al.
Published: (2025-07-01)

A Novel Bacteriophage with the Potential to Inhibit <i>Fusobacterium nucleatum</i>-Induced Proliferation of Colorectal Cancer Cells
by: Ho Yin Pekkle Lam, et al.
Published: (2025-01-01)

The role of Fusobacterium nucleatum in macrophage M2 polarization and NF-κB pathway activation in colorectal cancer
by: Wei Zheng, et al.
Published: (2025-04-01)

Tailoring a Functional Synthetic Microbial Community Alleviates Fusobacterium nucleatum‐infected Colorectal Cancer via Ecological Control
by: Zhongkun Zhou, et al.
Published: (2025-08-01)

Effect of a bacteriocin-producing Streptococcus salivarius on the pathogen Fusobacterium nucleatum in a model of the human distal colon
by: Garreth W. Lawrence, et al.
Published: (2022-12-01)

A Peptide‐Derived Aggregation‐Induced Emission Nanobioprobe: Unlocking Selective Detection of Fusobacterium nucleatum and Noninvasive Screening of Colorectal Cancer
by: Hongyu Liu, et al.
Published: (2025-04-01)

Association of <i>SEPT9</i> Gene Methylation with the Clinicopathologic Features and <i>Fusobacterium nucleatum</i> Infection in Colorectal Cancer Patients
by: Siew-Wai Pang, et al.
Published: (2025-04-01)

Targeted elimination of Fusobacterium nucleatum alleviates periodontitis
by: Nil Yakar, et al.
Published: (2024-12-01)

Abscesses of the spine and iliac fossa caused by infection with the opportunistic bacterium Fusobacterium nucleatum
by: YunTao Gu, et al.
Published: (2025-01-01)

Preoperative metronidazole treatment to evaluate its efficacy in reducing Fusobacterium nucleatum colonisation in colorectal cancer patients: a proof-of-concept trial
by: S. De Dosso, et al.
Published: (2025-06-01)

Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance
by: Chun Ye, et al.
Published: (2024-12-01)

A gut-derived Streptococcus salivarius produces the novel nisin variant designated nisin G and inhibits Fusobacterium nucleatum in a model of the human distal colon microbiome
by: Garreth W. Lawrence, et al.
Published: (2025-02-01)

Ethanolamine-induced assembly of microcompartments is required for Fusobacterium nucleatum virulence
by: Dana S. Franklin, et al.
Published: (2025-02-01)

Oral Fusobacterium nucleatum exacerbates ulcerative colitis via the oral-gut axis: mechanisms and therapeutic implications
by: Zhaoyu Zheng, et al.
Published: (2025-04-01)

Fusobacterium nucleatum as an oral bacteria promotes the carcinogenesis of laryngeal cancer via upregulating YWHAZ
by: Yiyue Ren, et al.
Published: (2025-12-01)

Exploring the complex interplay between oral Fusobacterium nucleatum infection, periodontitis, and robust microRNA induction, including multiple known oncogenic miRNAs
by: Syam Jeepipalli, et al.
Published: (2025-07-01)

An antisense oligomer conjugate with unpredicted bactericidal activity against Fusobacterium nucleatum
by: Valentina Cosi, et al.
Published: (2025-06-01)

Role of Fusobacterium Nucleatum and Porphyromonas Gingivalis in Oral Cancer: A Literature Review
by: Durlak Urszula, et al.
Published: (2025-07-01)

Antibacterial effect of femtosecond laser against Enterococcus faecalis and Fusobacterium nucleatum biofilms on dentin: an in vitro study
by: Pei Liu, et al.
Published: (2025-03-01)

Intratumoral Fusobacterium nucleatum is associated with better cancer-specific survival in head and neck cancer patients
by: José Guilherme Datorre, et al.
Published: (2025-12-01)

Research on the Mechanism of Mannose Oligosaccharide Enhancing the Inhibitory Effect of Bifidobacterium breve on the Growth of Fusobacterium nucleatum
by: Xuyan ZHANG, et al.
Published: (2025-01-01)

Interaction Between <i>Enterococcus faecalis</i> and <i>Fusobacterium nucleatum</i> Regulated Macrophage Transcriptional Profiling and Reprogrammed Cellular Immune and Metabolic Response
by: Jingheng Liang, et al.
Published: (2025-06-01)

Fusobacterium nucleatum exacerbates colitis via STAT3 activation induced by Acetyl-CoA accumulation
by: Zixuan Xiang, et al.
Published: (2025-12-01)

The surface protein Gbp of Fusobacterium nucleatum inhibits osteogenic differentiation by inactivating the Wnt/β-catenin pathway via binding to Annexin A2
by: Rui Dong, et al.
Published: (2025-05-01)

<i>Fusobacterium nucleatum</i> Is Associated with Tumor Characteristics, Immune Microenvironment, and Survival in Appendiceal Cancer
by: Christopher Sherry, et al.
Published: (2025-07-01)

Secretory IgA dysfunction underlies poor prognosis in Fusobacterium-infected colorectal cancer
by: Ilseok Choi, et al.
Published: (2025-12-01)

Guanxinning attenuates diabetic myocardial ischemia–reperfusion injury by targeting oral Fusobacterium nucleatum and modulating PTEN signaling
by: Yiwen Li, et al.
Published: (2025-06-01)

Impact of Sociodemographic, Clinical, and Genetic Factors and Fusobacterium nucleatum on Premature Birth Outcomes in Women from Kazakhstan: A Case-Control Study
by: Gulmira Zhurabekova, et al.
Published: (2025-08-01)

Unveiling the complex extra‐oral colonization pathways and pathogenic mechanisms of Fusobacterium nucleatum, a heterogeneous oral pathogen
by: Zhiwei Guan, et al.
Published: (2025-06-01)

Enhancing fibroblast–epithelial cell communications: Serpine2 as a key molecule in Fusobacterium nucleatum–promoted colon cancer
by: Xueke Li, et al.
Published: (2025-06-01)